For: | Li M, Liu GT. Inhibition of Fas/FasL mRNA expression and TNF-α release in concanavalin A-induced liver injury in mice by bicyclol. World J Gastroenterol 2004; 10(12): 1775-1779 [PMID: 15188504 DOI: 10.3748/wjg.v10.i12.1775] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1775.htm |
Number | Citing Articles |
1 |
Zheng Huai Tan, Ling Hong Yu, Huai Lin Wei, Geng Tao Liu. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice. Journal of Pharmacy and Pharmacology 2007; 59(1): 115 doi: 10.1211/jpp.59.1.0015
|
2 |
Sultan Alqahtani, Ayman M. Mahmoud, José Luís García-Giménez. Gamma‐Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide‐Induced Liver Injury and Hematologic Alterations via Upregulation of PPARγ and Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/4016209
|
3 |
Wenjun Shang, Yonghua Feng, Jinfeng Li, Xinzhou Wang, Hongchang Xie, Guiwen Feng. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation. Open Medicine 2017; 12(1): 62 doi: 10.1515/med-2017-0012
|
4 |
Águeda González-Rodríguez, Bjorn Reibert, Thomas Amann, Rainier Constien, Cristina M. Rondinone, Ángela M. Valverde. In vivosiRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates Concanavalin A-induced acute liver injury in mice. Disease Models & Mechanisms 2014; doi: 10.1242/dmm.015537
|
5 |
M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy. Bicyclol in the treatment of patients with chronic diffuse liver diseases. Meditsinskiy sovet = Medical Council 2020; (15): 78 doi: 10.21518/2079-701X-2020-15-78-89
|
6 |
Hua Sun, Linghong Yu, Huailing Wei, Gengtao Liu. A Novel Antihepatitis Drug, Bicyclol, Prevents Liver Carcinogenesis in Diethylnitrosamine-Initiated and Phenobarbital-Promoted Mice Tumor Model. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/584728
|
7 |
Hua Sun, Geng-Tao Liu. Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanisms. Journal of Asian Natural Products Research 2009; 11(6): 576 doi: 10.1080/10286020902942368
|
8 |
Ying-Nan Yu, Hui Chen, Yan Li. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice. Archives of Toxicology 2009; 83(4): 381 doi: 10.1007/s00204-008-0370-2
|
9 |
Hongxue Li, Qian Xu, Chengye Xu, Yuxin Hu, Xingyang Yu, Kangqi Zhao, Mingqing Li, Meng Li, Junfang Xu, Hongyu Kuang. Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.644129
|
10 |
Yong-Zhan Zhen, Na-Ren Li, Hong-Wei He, Shuang-Shuang Zhao, Guang-Ling Zhang, Xiao-Fang Hao, Rong-Guang Shao. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats. World Journal of Gastroenterology 2015; 21(23): 7155-7164 doi: 10.3748/wjg.v21.i23.7155
|
11 |
Qing-Wei Hu, Geng-Tao Liu. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action. Life Sciences 2006; 79(6): 606 doi: 10.1016/j.lfs.2006.02.025
|
12 |
Si-Yuan Pan, Hang Dong, Zhi-Ling Yu, Xin-Ye Zhao, Chun-Jing Xiang, Hui Wang, Wang-Fun Fong, Kam-Ming Ko. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. Journal of Pharmacy and Pharmacology 2007; 59(12): 1657 doi: 10.1211/jpp.59.12.0007
|
13 |
Hui-Juan Dai, Da-Wei Li, Ya-Xiang Wang, Ai-Jun Sun, Yi-Xian Lu, Xin- Ding, Ming- Zhang, Yong-Gang Song, Xuan-Dong Huang. Induction of heat shock protein 27 by bicyclol attenuates d-galactosamine/lipopolysaccharide-induced liver injury. European Journal of Pharmacology 2016; 791: 482 doi: 10.1016/j.ejphar.2016.09.002
|
14 |
Courtney M. Lappas , Yuan-Ji Day , Melissa A. Marshall , Victor H. Engelhard , Joel Linden . Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation . The Journal of Experimental Medicine 2006; 203(12): 2639 doi: 10.1084/jem.20061097
|
15 |
Xucong Huang, Mengqi Jia, Yanchao Liu, Shuowen Wang, Yuanjun Tang, Xiaojing Li, Xinhui Jiang, Zhenghua Wu, Yuefen Lou, Guorong Fan. Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity prediction. Journal of Pharmaceutical and Biomedical Analysis 2022; 220: 114947 doi: 10.1016/j.jpba.2022.114947
|
16 |
Edwina S. Baskin-Bey, Wendong Huang, Norihisa Ishimura, Hajime Isomoto, Steven F. Bronk, Karen Braley, Ruth W. Craig, David D. Moore, Gregory J. Gores. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology 2006; 44(1): 252 doi: 10.1002/hep.21236
|
17 |
V. T. Ivashkin, K. L. Raikhelson, L. K. Palgova, M. V. Maevskaya, O. A. Gerasimova, E. A. Kondrashina, N. V. Marchenko, A. Yu. Baranovsky. Drug-induced liver injury in cancer patients. Oncohematology 2020; 15(3): 80 doi: 10.17650/1818-8346-2020-15-3-80-94
|
18 |
Shu Jia, Lianyu Jin, Xiaoyan Cheng, Jingyi Wu, Xiaokun Yao, Jingping Shao, Congcong Zhang, Danwei Cen, Bin Cheng, Jing Wang, Lei Chen, Xiaomin Yao. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice. Drug Development and Industrial Pharmacy 2022; 48(6): 247 doi: 10.1080/03639045.2022.2106238
|
19 |
Ming-Wei Wang, Xiaojiang Hao, Kaixian Chen. Biological screening of natural products and drug innovation in China. Philosophical Transactions of the Royal Society B: Biological Sciences 2007; 362(1482): 1093 doi: 10.1098/rstb.2007.2036
|
20 |
Ying‐Nan Yu, Hui Chen, Yan Li. Effect of Bicyclol on Cisplatin‐Induced Hepatotoxicity in the Hepatocarcinoma 22 Tumour‐Bearing Mice. Basic & Clinical Pharmacology & Toxicology 2009; 104(4): 300 doi: 10.1111/j.1742-7843.2008.00343.x
|
21 |
K Wang. Molecular mechanisms of hepatic apoptosis. Cell Death & Disease 2014; 5(1): e996 doi: 10.1038/cddis.2013.499
|
22 |
Haidan Yuan, Qianqian Ma, Li Ye, Guangchun Piao. The Traditional Medicine and Modern Medicine from Natural Products. Molecules 2016; 21(5): 559 doi: 10.3390/molecules21050559
|
23 |
Cancer Biology and Advances in Treatment. Advances in Experimental Medicine and Biology 2020; 1292: 157 doi: 10.1007/5584_2020_525
|
24 |
Ayman M. Mahmoud, Omnia E. Hussein, Walaa G. Hozayen, Sanaa M. Abd El-Twab. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: Protective effect of 18β-Glycyrrhetinic acid. Chemico-Biological Interactions 2017; 270: 59 doi: 10.1016/j.cbi.2017.04.009
|
25 |
Jianzuo Yao, Jingyi Wu, Shu Jia, Jingping Shao, Xie Zhang, Zeping Xu, Hui Zhang, Hong Li, Xiaomin Yao. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum. Journal of Clinical Laboratory Analysis 2022; 36(12) doi: 10.1002/jcla.24793
|
26 |
Vladimir T. Ivashkin, Andrey Yu. Baranovsky, Karina L. Raikhelson, Lyudmila K. Palgova, Marina V. Maevskaya, Elina A. Kondrashina, Natalya V. Marchenko, Tatyana P. Nekrasova, Igor G. Nikitin. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 101 doi: 10.22416/1382-4376-2019-29-1-101-131
|
27 |
Wen Xie, Guangfeng Shi, Hongfei Zhang, Guiming Zhao, Zujiang Yu, Zhenwei Lang, Hong Zhao, Jie Yan, Jun Cheng. A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatology International 2012; 6(2): 441 doi: 10.1007/s12072-011-9294-7
|
28 |
I. Yu. Pirogova, S. V. Yakovleva, T. V. Neuymina, S. P. Sinitsyn, V. S. Chulkov, T. N. Shamaeva. Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study. Rossijskij žurnal gastroènterologii gepatologii koloproktologii 2018; 28(4): 66 doi: 10.22416/1382-4376-2018-28-4-66-75
|
29 |
Sunil Kumar Verma, Minakshi Pandey, Avinash Sharma, Devendra Singh. Exploring Ayurveda: principles and their application in modern medicine. Bulletin of the National Research Centre 2024; 48(1) doi: 10.1186/s42269-024-01231-0
|
30 |
Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. International Immunopharmacology 2021; 91: 107308 doi: 10.1016/j.intimp.2020.107308
|
31 |
Hua Sun, Geng-Tao Liu. Chemopreventive effect of bicyclol on malignant transformation of WB-F344 rat liver epithelial cells and its effect on related signal transduction in vitro. Cancer Letters 2006; 236(2): 239 doi: 10.1016/j.canlet.2005.05.019
|
32 |
Xiu-Qi Bao, Geng-Tao Liu. Induction of Overexpression of the 27- and 70-kDa Heat Shock Proteins by Bicyclol Attenuates Concanavalin A-Induced Liver Injury through Suppression of Nuclear Factor-κB in Mice. Molecular Pharmacology 2009; 75(5): 1180 doi: 10.1124/mol.108.053280
|
33 |
Yan Hou, Libo Li, Huailing Wei, Liping Wu, Yuanfeng Tong, Song Wu, Gengtao Liu. Protection by bicyclol derivatives against acetaminophen‐induced acute liver failure in mice and its active mechanism. Liver International 2008; 28(9): 1226 doi: 10.1111/j.1478-3231.2008.01757.x
|